Skip to main content
Clinical Trials/JPRN-UMIN000049726
JPRN-UMIN000049726
Not yet recruiting
未知

Prospective observational study on pain relief, functional evaluation and safety of human adipose-derived mesenchymal stem cell culture supernatant solution for acute and chronic pain Singl-center, single-arm open study - MSC-CM Trial

General incorporated association Advalife Science SINCLAIR GINZA CLINIC0 sites30 target enrollmentDecember 8, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Acute pain and Chronic pain
Sponsor
General incorporated association Advalife Science SINCLAIR GINZA CLINIC
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 8, 2022
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
General incorporated association Advalife Science SINCLAIR GINZA CLINIC

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients who have taken anti\-inflammatory analgesics within 8 hours prior to the administration of the study drug 2\. Patients who have used sleeping pills, psychotropic drugs, or other psychiatric drugs within 24 hours prior to administration of the study drug 3\. Patients suffering from infectious diseases 4\. Patients with a history of cancer or active malignancy 5\. Patients with hypoglycemic symptoms prior to administration of the study drug 6\. Patients who are judged to be inappropriate as research subjects by the principal investigator and principal study investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials